Search Results

has also received both Junior (2001) and Senior (2005) investigator awards from the Pharmacological Society

John Janetzko "I received my Honors BSc in Chemistry from the University of Toronto in 2011, with a focus on synthetic organic and inorganic chemistry. Following this, I pursued graduate studies in Chemistry at Harvard University. He participated in various academic competitions, including math, physics, and chemistry contests. John's Chemistry Olympiad and GPCR Journey John shared his experience with the Chemistry Olympiad program

Ross Cheloha is an Investigator at the National Institutes of Health in the Laboratory of Bioorganic Chemistry He earned his Ph.D. in Chemistry at the University of Wisconsin-Madison in the lab of Sam Gellman on Work in his independent laboratory is focused on developing new pharmacological tools via chemistry and

Jacobson received his BA in Liberal Arts from Reed College in 1976 and his Ph.D. in Chemistry from the currently the Senior Investigator and Chief of the Molecular Recognition Section, Laboratory of Bioorganic Chemistry His numerous awards include: 2008 Sato Award; 2009 Medicinal Chemistry Hall of Fame (American Chemical

Maria Majellaro earned her degree in Pharmaceutical Chemistry and Technology from the University of Bari Her work focuses on organic synthesis, medicinal chemistry, and the development of GPCR-targeted tools Podcast Episode Baking Molecules, Building Probes: When Chemists Think Like Biologists Episode #168 • Maria Majellaro "We always start with the problem, then generate the right compound using our chemistry

Masha earned her Bachelor’s degree in chemistry, followed by a direct Ph.D. at the Institute of Chemistry

Matthew Eddy Matthew Eddy earned his BA in Chemistry from Oberlin College, where he trained with solid-state He then earned his Ph.D. in physical chemistry from the Massachusetts Institute of Technology, training

Bridging computation, chemistry, and pharmacology is key to speeding up drug discovery. when building a research career Who Should Listen GPCR scientists and pharmacologists Computational chemists With a reputation for collaborative science, Jens is a strong advocate for bringing together chemists

With a career spanning two decades at the intersection of fluorescence chemistry, functional assays, How collaborations with David Parker and Jean-Philippe Pin accelerated both probe chemistry and biological Originally trained as a physicist with a strong interest in photophysics and fluorescence chemistry, His passion lies in turning cutting-edge probe chemistry into robust, scalable tools for drug discovery

Christel Menet "I did my Ph.D. in Manchester UK with Prof Jonathan Clayden in organic chemistry. After 2 years, I joined Galapagos where I spent almost 11 years and became head of medicinal chemistry

Terry Kenakin After obtaining a BSc in chemistry at the University of Alberta Edmonton Canada, Terry received his Ph.D. in Pharmacology from the University of Alberta, Department of Chemistry, Canada.

He received his B.S. in Chemistry from Duke University in 2016 where he worked in the lab of Dr. Stephen Craig and studied polymer chemistry and material science.

A native of Italy, she received her Bachelor’s and Master’s degrees in Chemistry from the University She pursued a Ph.D. in Computational Chemistry at the Second University of Naples and a postdoctorate

While a chemistry undergraduate student at the University of Chicago, he attended a NATO Advanced Study Gobind Khorana at the Department of Chemistry at M.I.T. for postdoctoral training, where he learned gene including Richard Mathies and Fritz Siebert , and contributed substantially to elucidating the physical chemistry

Lefkowitz, M.D., 2012 Nobel Prize in Chemistry, which he shared with Dr. Brian Kobilka . Duke Professor of Medicine and Professor of Biochemistry, Chemistry, and Pathology at the Duke University

visualization tools changed our understanding of GPCR signaling in metabolic tissues What collaborative chemistry innovation with the need for reproducible, well-controlled functional assays Worked across disciplines where chemistry

Hildebrand2, Norbert Sträter1 1 Institute of Bioanalytical Chemistry, Leipzig University, Deutscher Platz Sträter Oct 2011 – Mar 2016 Master of Science in chemistry, University Leipzig Oct 2008 – Sep 2011 Bachelor of Science in chemistry, University Leipzig" Fabian Pohl on the web Langenhan Lab Structural studies of General Biochemistry, Medical Faculty, Leipzig University, Germany 3 Institute of Bioanalytical Chemistry

Kaavya Krishna Kumar on the web Journal of Biology Chemistry Stanford University Google Scholar LinkedIn

Brian Shoichet BSc in Chemistry from MIT, Ph.D. with Tack Kuntz at UCSF; Postdoc with Brian Matthews

Strategic Partner(s) Eleonora Comeo About this episode Eleonora Comeo is a doctoral candidate in Medicinal Chemistry

pharmacology - UK April 3 - 6, 2025 | ASPET 2025 - USA NEW April 14 - 17, 2025 | 20th Drug Discovery Chemistry - 2, 2025 | 5th Ace Drug Discovery Summit 2025 - USA NEW May 12 - 15, 2025 | ACSMEDI-EFMC Medicinal Chemistry University Structural Biologist - Confo Therapeutics Associate Director/Director, Platform & Hit-ID Chemistry

Prior to experiences at PerkinElmer and BioTek, Banks was an Assistant Professor in Analytical Chemistry

he completed a PhD in protein engineering (Cambridge, UK) with Sir Gregory Winter (Nobel Prize for Chemistry

Gardner About Julia Gardner Julia is a senior undergraduate student at Duke University, where she studies chemistry

Ilana graduated Summa cum laude from Cornell University, where she studied Chemistry and Chemical Biology

Kathryn obtained her BS in Chemistry from Carnegie Mellon University and went on to receive a Ph.D. in

After spending two years at the Cleveland Institute of Art, he earned degrees in Biochemistry and Chemistry

Vaidehi received her Ph.D. in quantum chemistry from the Indian Institute of Technology in India, where

He obtained his B.S. in Chemistry from The University of Chicago in 1998 and subsequently enrolled in

By the end of 2021, I moved back to Germany and joined the pharmaceutical chemistry group of Peter Kolb